InsiderSignal.AI

InsiderSignal.ai

APGE - Apogee Therapeutics, Inc.

Insider Sale by Henderson Michael Thomas (CEO)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

1 week ago, Henderson Michael Thomas, serving as CEO at Apogee Therapeutics, Inc. (APGE), sold 20,000 shares at $82.58 per share, for a total transaction value of $1,651,664.00. Following this transaction, Henderson Michael Thomas now holds 1,132,987 shares of APGE.

This sale represents a 2.00% decrease in Henderson Michael Thomas's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, April 8, 2026 and publicly disclosed via SEC Form 4 filing on Friday, April 10, 2026, 2 days after the trade was made.

Apogee Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Henderson Michael Thomas

CEO

Michael Thomas Henderson is the Chief Executive Officer of Apogee Therapeutics, Inc. (APGE), where he owns approximately 1,302,987 shares valued at over $48 million as of early 2025.[[4]](https://www.gurufocus.com/insider/128956/michael-thomas-henderson) He recently engaged in insider trading activities at APGE, with an estimated net worth exceeding $57 million, including holdings in BridgeBio Pharma Inc. (BBIO).[[4]](https://www.gurufocus.com/insider/128956/michael-thomas-henderson)[[6]](https://www.benzinga.com/sec/insider-trades/0001779990/michael-thomas-henderson) A seasoned healthcare executive with over 20 years as a serial CEO in healthcare technology, Henderson has raised $125 million in capital, achieving shareholder returns from 4x to 80x, including one IPO and one acquisition.[[1]](https://noblereach.org/person/michael-thomas/) Previously, he served as CEO of iSonea Ltd (ASX:ISN), growing its market cap from $4 million to $250 million in under three years, and founded Appian Medical and Wakyn Sleep Technologies.[[1]](https://noblereach.org/person/michael-thomas/) He is a Managing Partner at Bold Brain Capital, a VC firm focused on AI-enabled imaging startups, and holds board positions including Director at Spyre Therapeutics Inc. (SYRE) and Adagio Medical Holdings Inc. (ADGM).[[1]](https://noblereach.org/person/michael-thomas/)[[4]](https://www.gurufocus.com/insider/128956/michael-thomas-henderson) His experience includes venture capital at Inova Health System Strategic Investments and advisory roles with the NobleReach Foundation and ARPA-H.[[1]](https://noblereach.org/person/michael-thomas/)

View full insider profile →

Trade Price

$82.58

Quantity

20,000

Total Value

$1,651,664.00

Shares Owned

1,132,987

Trade Date

Wednesday, April 8, 2026

7 days ago

SEC Filing Date

Friday, April 10, 2026

Filed 2 days after trade

HEALTHCAREBIOTECHNOLOGY

About Apogee Therapeutics, Inc.

Company Overview

No company information available
View news mentioning APGE

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5609184

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime